The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
Open accessAbstract
Case reports indicate that psychiatrists administered ±3,4-methylenedioxymethamphetamine (MDMA) as a catalyst to psychotherapy before recreational use of MDMA as 'Ecstasy' resulted in its criminalization in 1985. Over two decades later, this study is the first completed clinical trial evaluating MDMA as a therapeutic adjunct. Twenty patients with chronic posttraumatic stress disorder, refractory to both psychotherapy and psychopharmacology, were randomly assigned to psychotherapy with concomitant active drug (n = 12) or inactive placebo (n = 8) administered during two 8-h experimental psychotherapy sessions. Both groups received preparatory and follow-up non-drug psychotherapy. The primary outcome measure was the Clinician-Administered PTSD Scale, administered at baseline, 4 days after each experimental session, and 2 months after the second session. Neurocognitive testing, blood pressure, and temperature monitoring were performed. After 2-month follow-up, placebo subjects were offered the option to re-enroll in the experimental procedure with open-label MDMA. Decrease in Clinician-Administered PTSD Scale scores from baseline was significantly greater for the group that received MDMA than for the placebo group at all three time points after baseline. The rate of clinical response was 10/12 (83%) in the active treatment group versus 2/8 (25%) in the placebo group. There were no drug-related serious adverse events, adverse neurocognitive effects or clinically significant blood pressure increases. MDMA-assisted psychotherapy can be administered to posttraumatic stress disorder patients without evidence of harm, and it may be useful in patients refractory to other treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MDMA’s softening of rigid self-protective mechanisms reduces interpersonal defensiveness, and increases sensitivity to emotional and relational dynamics, allowing for deeper engagement in the therapeutic process (88, 100, 102).”
From Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach (2025) · cites this paper as [102]
Experimental — accuracy not yet measuredIn the citing paper
“Several small trials suggest that MDMA-assisted psychother apydoes have a superior effect 148,149 , and large multi-site studies are now underway 150 .”
From Post‐traumatic stress disorder: a state‐of‐the‐art review of evidence and challenges (2019) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Emotional processing of fear: Exposure to corrective information.
Foa, E. B., & Kozak, M. J. (1986) · Psychological Bulletin · doi:10.1037/0033-2909.99.1.20 · Cited by 5,396
Combat Duty in Iraq and Afghanistan, Mental Health Problems, and Barriers to Care
Hoge, C. W., Castro, C. A., Messer, S. C., McGurk, D., Cotting, D. I., & Koffman, R. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040603 · Cited by 4,778
Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690
The Impact of Event Scale: Revised
Weiss, D. S. (2007) · Springer eBooks · doi:10.1007/978-0-387-70990-1_10 · Cited by 3,074
Randolph, C., Tierney, M. C., Mohr, E., & Chase, T. N. (1998) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.20.3.310.823 · Cited by 2,519
Paced Auditory Serial-Addition Task: A Measure of Recovery from Concussion
Gronwall, D. M. A. (1977) · Perceptual and Motor Skills · doi:10.2466/pms.1977.44.2.367 · Cited by 2,395
Clinician-administered PTSD scale: A review of the first ten years of research
Weathers, F. W., Keane, T. M., & Davidson, J. R. T. (2001) · Depression and Anxiety · doi:10.1002/da.1029 · Cited by 1,903
Adamson, D. M., Burnam, M. A., Burns, R. M., Caldarone, L. B., Cox, R. A., D’Amico, E. J., Díaz, C., Eibner, C., Fisher, G., Helmus, T. C., et al. (2008) · RAND Corporation eBooks · doi:10.7249/mg720 · Cited by 1,713
Freeman, A. M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1112 · Cited by 1,667
Research works printed but not linked: 14
- Breslau N, 2001, J Clin Psychiatry, 62, 16
- Cloitre M, 2009, CNS Spectr, 14, 32
- Committee on Treatment of Posttraumatic Stress Disorder, Institute of Medicine, 2008, Posttraumatic stress disorder: an assessment of the evidence
- Derogatis LR, 1994, SCL-90-R: Administration, Scoring and Procedures Manual
- First MB, 1997, Structured clinical interview for Axis II DSM-IV disorders: Patient Edition (SCID II)
- First MB, 1994, Structured clinical interview for Axis I DSM -IV disorders: Patient Edition (SCID-I/P)
- Grof S, 2000, Psychology of the Future
- Ipser J, 2006, S Afr Med J, 96, 1088
- Metzner R, 2001, Ecstasy: the complete guide, 182
- Ogden PKM, 2006, Trauma and the body
- Pahnke WN, 1971, Int J Clin Pharmacol, 4, 446
- Stein DJ, 2009, CNS Spectr, 14, 25
- 10.1038/sj.npp.1395197 · DOI · Paper page
- Wilbarger P, 1997, Sensory defensiveness and related social/emotional and neurological problems
Cited by
Sorted by citations
Items 601–671 of 671
INTRODUCTION: A New Approach for the Whole Person
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0001
Choosing Suggested Integration Goals
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.005.0004
Working Within the EMBARK Domains Cheat Sheet
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.005.0003
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0007
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.005.0002
An Overview of Psychedelic-Assisted Therapy
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0002
Personal Care for the Therapist
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.005.0001
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0008
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.002.0004
EMBARK Mechanisms of Change in the Treatment of Depression
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0004
Bioisosteric analogs of MDMA with improved pharmacological profilePreprint
Alberto‐Silva, A. S., Hemmer, S., Bock, H. A., da Silva, L. A., Scott, K. R., Kastner, N., Bhatt, M., Niello, M., Jäntsch, K., Kudlacek, O., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.08.588083
Nunes, J. M. P. F. (2024) · doi:10.56161/sci.ed.20240220033c1
Bechtold, L., & Repantis, D. (2024) · Nervenheilkunde · doi:10.1055/a-2278-8335
The Long Road Toward Equitable MDMA Treatment in the United States
Kozak, Z., & Aaronson, S. T. (2024) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.23com15224
Rath, A. P. (2024) · Journal of Community Pharmacy Practice · doi:10.55529/jcpp.44.1.9
The Conceptual Framework for the Therapeutic Approach used in Phase 3 Trials of MDMA-AT for PTSDPreprint
O’Donnell, K. C., Alpert, M., Okano, L., Nicholas, C. R. N., Thomas, C., Poulter, B., Mithoefer, A. T., Mithoefer, M. C., & Marcela Ot’alora, G. (2024) · doi:10.31219/osf.io/gey78
Baikady, R. (2025) · Springer eBooks · doi:10.1007/978-981-96-1828-6_5
Groeneveld, M., & Harper, T. (2024) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/aps5g_v1
PSYCHOLOGICAL TRENDS IN THE TREATMENT OF PTSD
Griffiths, G. (2024) · E-Journal VFU · doi:10.53606/evfu.22.105-118
(2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926939.002.0007
Foa, E. B., Hembree, E. A., ROTHBAUM, B. O., & Rauch, S. A. M. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926939.005.0002
Foa, E. B., Hembree, E. A., ROTHBAUM, B. O., & Rauch, S. A. M. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926939.005.0001
Therapist Imaginal Exposure Recording Form
Foa, E. B., Hembree, E. A., ROTHBAUM, B. O., & Rauch, S. A. M. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926939.005.0003
Foa, E. B., Hembree, E. A., ROTHBAUM, B. O., & Rauch, S. A. M. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926939.002.0004
Foa, E. B., Hembree, E. A., ROTHBAUM, B. O., & Rauch, S. A. M. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926939.002.0010
Foa, E. B., Hembree, E. A., ROTHBAUM, B. O., & Rauch, S. A. M. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926939.002.0005
Prolonged Exposure Treatment Session Checklists
Foa, E. B., Hembree, E. A., ROTHBAUM, B. O., & Rauch, S. A. M. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926939.005.0004
Groeneveld, M., & Harper, T. (2025) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/aps5g_v4
Rauch, S. A. M., Rothbaum, B. O., Smith, E. R., & Foa, E. B. (2020) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190081928.005.0003
(2020) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190081928.002.0008
Therapist and Patient Handouts
Rauch, S. A. M., Rothbaum, B. O., Smith, E. R., & Foa, E. B. (2020) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190081928.005.0001
Rauch, S. A. M., Rothbaum, B. O., Smith, E. R., & Foa, E. B. (2020) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190081928.005.0002
Rauch, S. A. M., Rothbaum, B. O., Smith, E. R., & Foa, E. B. (2020) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190081928.002.0005
Rauch, S. A. M., Rothbaum, B. O., Smith, E. R., & Foa, E. B. (2020) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190081928.002.0004
Rauch, S. A. M., Rothbaum, B. O., Smith, E. R., & Foa, E. B. (2020) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190081928.002.0009
Psychedelics’ Intoxicating Impact and Behavioural Dynamics
Wasti, A. Z. (2025) · Pharmaceutical science. · doi:10.5772/intechopen.1011743
The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives
Rahmani, S., Crupi, R., Riley, A. L., & Davidson, T. L. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174087
Ahari, N. J., & Fonzo, G. A. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1665770 · Cited by 1
MDMA in Psychiatry: From PTSD to emerging indications, safety, and future directions
Zhao, M., Yang, J., & Hashimoto, K. (2025) · Psychedelics. · doi:10.61373/pp025i.0035
Jin, S., Wang, H., & Wang, X. (2025) · Psychedelics. · doi:10.61373/pp025v.0038
The Potential Therapeutic Effects of MEAI in the Treatment of Alcohol Use Disorder
Ekhlasi, M., Frytz, A., & Nia, A. B. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00700-4
Chapter 9. Club Drugs and Inhalants
Rosenthal, R. N., & Tsoy-Podosenin, M. (2025) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894550862.lg09
Maeder, S., Fahim, C., & Martin-Söelch, C. (2025) · Cortica · doi:10.26034/cortica.2025.8925
Bhagavan, C., Glue, P., Evans, W., Reynolds, L., Turner, T., King, C., Russell, B. R., Morunga, E., Mills, J. L., Layton, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25876232
Bhagavan, C., Glue, P., Evans, W., Reynolds, L., Turner, T., King, C., Russell, B. R., Morunga, E., Mills, J. L., Layton, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25876328
Bhagavan, C., Glue, P., Evans, W., Reynolds, L., Turner, T., King, C., Russell, B. R., Morunga, E., Mills, J. L., Layton, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26723801
“Tragic Person evolved: Transforming tragedy into hope through new, alternative treatments”
Zimmerman, D. (2025) · Psychoanalysis Self and Context · doi:10.1080/24720038.2025.2604803
Wongpaiboon, M., Shelton, J. L., Rendon, E. D., & Vail, M. (2025) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-025-00373-w
Choreographing time: toward therapy-aligned entactogens for complex PTSD
Parikh, A. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-025-02314-w
Santé mentale et psychédéliques : révolution ou promesse utopique ?
Duguey, A. L., Fauvel, B., & Bioy, A. (2025) · Perspectives Psy · doi:10.1051/ppsy/2025055
COSMITO: Cognitive Outer Space Monitor and Individual Therapeutic Outfit
Betancur, E. R., & Zhang, M. (2026) · International Conference on Tangible, Embedded, and Embodied Interaction (TEI) · doi:10.1145/3731459.3779346 · Cited by 1
Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil
Portes, M. A. M., & Bertoglio, L. J. (2026) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2026.2644865
Gu, E. Y., Irvine, N. M., Miller, M. J., Ramirez, E., Santaella-Tenorio, J., Lippincott, T., Bogenschutz, M. P., Bunting, A. M., Meacham, M. C., & Krawczyk, N. (2026) · Journal of Psychedelic Studies · doi:10.1556/2054.2026.00487
Comparison of Psychotherapies, Pharmacotherapies and Neurotherapies for PTSD
Bennett, M. (2026) · Springer eBooks · doi:10.1007/978-981-95-9594-5_16
Bennett, M. (2026) · Springer eBooks · doi:10.1007/978-981-95-9594-5_8
Psychedelics and neurostimulation for treatment resistant psychiatric disorders
Blažek, F., Látalová, K., Krahulík, D., & Hrabálek, L. (2026) · Discover Mental Health · doi:10.1007/s44192-026-00486-5
Psychedelic-Assisted Psychotherapy for the Treatment of PTSD: A Systematic Review and Meta-Analysis
Mitter, F., Sheptooha, A., Leung, J., Ketheesan, S., & Akóṣílè, W. (2026) · Psychoactives · doi:10.3390/psychoactives5020016
The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review
Ferreira, F. G. D. P., Fernandes, J. A. B., Filev, R., da Silveira, D. X., & Fidalgo, T. M. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261453850
Policy Considerations for Psychedelics in Research and Medicine – What’s Next on the Schedule?
Boehm, M. A., & Mayorga, O. (2026) · Journal of Science Policy & Governance · doi:10.38126/jspg280103
Kasiviswanathan, K., Nilaweera, D., Morando, M., Rao, S., Lee, J., Fettling, J., & Broadbear, J. H. (2026) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253251408626
Potential Role of Psychedelics in the Treatment of Depressive Disorder
Wang, S., & Bahk, W.-M. (2026) · Springer eBooks · doi:10.1007/978-981-92-1331-3_12
Psychologists’ attitudes towards the use of MDMA in therapy may be shaped by personal experiences
Csákó, R. I., Shepherd, D., Vitális, E. ́., & Cullen, D. (2026) · Clinical Psychologist · doi:10.1080/13284207.2026.2703685
Kelly, C., Cooley, B. J., Zeng, L., Hurzeler, T. P., Manning, V., McNally, G. P., Watt, J., Haber, P., & Morley, K. C. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106911
Psilocybin-Assisted Therapy for Alcohol Use Disorder: A Systematic Review of Clinical Evidence
Schäffert, L., & Unterrainer, . (2026) · Psychoactives · doi:10.3390/psychoactives5030022
Green, W., Raut, S. B., James, F. L. J., Benedek, D. M., Ursano, R. J., Capaldi, V. F., & Johnson, L. R. (2026) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000478
Ehrenkranz, R. C., Sepeda, N. D., Goldy, S. P., Weiss, B., Tiwari, P., Azimi, A., & Yaden, D. B. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261473405
Sevchik, B. L., Singleton, S. P., Lahey, A., Cuijpers, P. J., Harrer, M., Jones, M. T., Nayak, S. M., Strain, E. C., Vandekar, S., Yaden, D. B., et al. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02575-z
Goldy, S. P., Klein, K. A., Yaden, D. B., & Nayak, S. M. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07187-5
Metadata
- Authors
- Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R.
- Affiliations
- Private Practice of Psychiatry and Clinical Research, Mount Pleasant SC, USA.
- Medical University of South Carolina (US)
- Multidisciplinary Association for Psychedelic Studies (US)
- Corresponding author
- Mithoefer, Michael C
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2010-07-19
- Volume
- 25
- Issue
- 4
- Pages
- 439-452
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- PMC
- PMC3122379
- OpenAlex
- W2089149909
- Cited by
- 674
- References
- 67
- Citations by year
- 2026: 30 · 2025: 36 · 2024: 75 · 2023: 49 · 2022: 52 · 2021: 41 · 2020: 61 · 2019: 62 · 2018: 59 · 2017: 45 · 2016: 28 · 2015: 27 · 2014: 23 · 2013: 44 · 2012: 26
- FWCI
- 29.42
- Type
- journal article
- Language
- en
- Update notices
- correction (2011-06-01)
- Open access
- hybrid
- doi.org
- Locations
- Journal of Psychopharmacology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- MDMA-assisted psychotherapy, MDMA, 3,4-methylenedioxymethamphetamine, post-traumatic stress disorder, treatment-resistant PTSD, chronic PTSD, psychedelic therapy, Clinician-Administered PTSD Scale, adverse events, neurocognitive effects, blood pressure
- MeSH terms
- Adult, Aged, Double-Blind Method, Fear, Female, Humans, Male, Middle Aged, Music Therapy, Pilot Projects, Placebos, Psychiatric Status Rating Scales, Psychotherapy, Stress Disorders, Post-Traumatic, Treatment Outcome, Serotonin Agents, Cross-Over Studies, N-Methyl-3,4-methylenedioxyamphetamine, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
